Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 70 results for "Suboxone Tablets"

Study Comparing Buprenorphine Implants to Suboxone Gets Underway
Partnership for Drug-Free Kids

Study Comparing Buprenorphine Implants to Suboxone Gets Underway

After the Food and Drug Administration (FDA) decided last year not to approve implantable buprenorphine to treat opioid abuse, researchers have begun a new study to address the agency's concerns about the product, called Probuphine. The study ... Partnership for Drug-Free Kids, 1 month ago

Orexo: Interim Report January-September 2014

UPPSALA, Sweden--(BUSINESS WIRE)-- Regulatory News: Orexo ( ORX.ST ): Unless otherwise stated in this report, all data refers to the Group. Figures in parentheses relate to the corresponding period in 2013. ZubsolvĀ® evolution ...
 Yahoo! Finance1 day ago
Securities Technology Monitor

Reckitt Benckiser Pharmaceuticals Inc. Announces Plans to Rebrand Under Indivior PLC Following Demerger

RICHMOND, Va., Oct. 21, 2014 /PRNewswire/ -- Reckitt Benckiser Pharmaceuticals Inc. (RBP) today announced its UK-based parent company, Reckitt Benckiser Group plc (RB), expects the proposed demerger of the RBP business to complete in 2014. Reckitt ...
 TickerTech.com2 days ago RECKITT BENCKISER PHARMACEUTICALS : Inc. Announces Plans to Rebrand Under Indivior PLC Following Demerger  4 Traders2 days ago
[x]  

Reckitt Benckiser Group PLC Q3 Interim Management Statement

TIDMRB. RNS Number : 8174U Reckitt Benckiser Group PLC 21 October 2014 INTERIM MANAGEMENT STATEMENT Q3 2014 21 October 2014 ROBUST PERFORMANCE IN CHALLENGING MARKETS Results at a glance Q3 % change % change YTD % change % change GBPm ...
 ADVFN UK2 days ago Reckitt Benckiser Group's (RBGPF) CEO Rakesh Kapoor on Q3 2014 Results - Earnings Call Transcript  Seeking Alpha2 days ago Q3 Interim Management Statement  TrustNet2 days ago

Strong Enrollment In Phase 3 Trial Means Good News For Titan Pharma

Summary Titan's confirmatory Phase 3 trial is enrolling well - slightly ahead of schedule. We believe this is a good sign and shows strong potential demand for the drug. Data from the Phase 3 trial is expected around the middle of 2015, with a NDA ...
 Seeking Alpha4 weeks ago

Roadblocks to Opiate Abuse

Many individuals live with pain, either chronic or acute. An estimated 100 million Americans suffer from chronic pain. 1 Pain causes stress and suppresses immune responses, which make medical problems worse. The use of opiates to manage pain has ...
 Psychiatric Times1 month ago Finding the sweet spot: Effective pain management and risk mitigation  Pharmacist.com1 month ago
Sott.net

Another deadly painkiller: Buprenorphine is 50 times stronger than morphine

Prescription painkiller and heroin addiction has laced its way through America, and effective anti-addiction treatments line the medicine cabinets of thousands of homes. Government researchers have discovered though drug treatment is effective in ...
 Sott.net1 month ago Buprenorphine Linked To Young Deaths; Medication 50 Times Stronger Than Morphine  Medical Daily1 month ago
CBS News

CBS Health: Anti-addiction drugs pose poisoning risk for kids

An anti-addiction drug used to fight the nation's heroin and painkiller abuse epidemics poses a threat to young children who accidentally swallow relatives' prescriptions, a federal study says. Some children have died. The study found that the ...
 CBS News1 month ago Kids Poisoned by Anti-addiction Med  Laboratory Equipment1 month ago Study: Kids' emergency hospitalizations tied to anti-addiction drug; packaging change may help  Huffington Post Canada1 month ago Kids' poisonings linked to anti-addiction medicine  Miami Herald1 month ago
[x]  
Canberra Times

Call for tighter codeine controls

Addiction in numbers. Doctors and pharmacists are calling for tighter controls on medicines containing codeine due to increasing concern about addiction, with users being referred to drug programs including methadone for treatment. With ...
 Canberra Times1 month ago Doctors and pharmacists call for tighter controls on codeine due to rise in addiction  Melbourne Age1 month ago
[x]  

BioDelivery Sciences International's (BDSI) CEO Presents at Morgan Stanley Healthcare Conference (Transcript)

Chris Caponetti - Morgan Stanley Thanks everyone for joining the BDSI session. I am Chris Caponetti and I encourage you to please visit morganstanley.com/researchdisclosures for disclaimers. With that it's my pleasure to welcome Mark Sirgo, ...
 Seeking Alpha1 month ago BioDelivery Sciences' (BDSI) Hosts Investor and Analyst Event on BUNAVAIL Launch and Pipeline (Transcript)  Seeking Alpha1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less